Concurrent chemoradiotherapy with or without low molecular weigth heparin (LWMH) in the treatment of locally avanced non-small cell lung cancer (NSCLC)

Isikdogan, A.Kaplan, M. A.Zincircioglu, S. B.Cit, M.Cil, T.Karadayi, B.Dirier, A.2024-04-242024-04-2420100732-183X1527-7755https://doi.org/10.1200/jco.2010.28.15_suppl.e17526https://hdl.handle.net/11468/18270[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]Concurrent chemoradiotherapy with or without low molecular weigth heparin (LWMH) in the treatment of locally avanced non-small cell lung cancer (NSCLC)Concurrent chemoradiotherapy with or without low molecular weigth heparin (LWMH) in the treatment of locally avanced non-small cell lung cancer (NSCLC)Conference Object2815WOS:00020885200133910.1200/jco.2010.28.15_suppl.e17526Q1